Apollo Hospitals Enterprise Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Apollo Hospitals Enterprise Share Price

8,524.00165.50 (1.99%)

Closed
As On: 09 Jun, 2026, 03:58 PM IST
As On: 09 Jun, 2026, 03:53 PM IST

Sector: Hospitals & All...
Industry: Hospital

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	8,420.00
High	8,538.50
Low	8,365.50
Prev Close	8,358.50
Volume	8,18,210
VWAP(₹)	8,485.39

Key Metrics

PE Ratio(x)	63.12
EPS - TTM(₹)	135.04
MCap(₹ Cr.)	1,22,562
MCap Rank	1
PB Ratio(x)	12.05
Div Yield(%)	0.23
Face Value(₹)	5.00
52W High(₹)	8,538.50
52W Low(₹)	6,696.50
MCap/Sales	4.23
Beta(1 Month)	1.67
BV/Share(₹)	693.71

Apollo Hospital share price insights

Rank 126 - ET 5002025 ranking

ROE Outperforming 5 Year Average
Company delivered ROE of 20.48% in year ending Mar 31, 2026 outperforming its 5 year avg. of 16.9%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.78% of its operating revenues towards interest expenses and 11.89% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Apollo Hospital Share Price Update
Apollo Hospitals Enterprise Ltd. share price moved up by 1.99% from its previous close of Rs 8,358.50. Apollo Hospitals Enterprise Ltd. stock last traded price is 8,524.00
Share Price Value
Today/Current/Last 8,524.008,525.60
Previous Day 8,358.508,354.55

Found Insights useful?

Apollo Hospital Share Price Returns

1 Day	1.99%
1 Month	5.27%
3 Months	9.24%
1 Year	23.21%
3 Years	73.02%
5 Years	156.31%

Apollo Hospital Share Recommendations

Mean recosCurrent

BUY

26 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	11	11	11	11
Buy	11	11	13	12
Hold	3	3	1	2
Sell	1	1	1	1
Strong Sell	-	-	-	-
# Analysts	26	26	26	26

Recent Recos

Target₹7500
OrganizationICICI Securities
ADD

Target₹8020
OrganizationMotilal Oswal Financial Services
BUY

Target₹7250
OrganizationHDFC Securities
BUY

View all Stock Recommendations

News & Analysis

View all Apollo Hospital Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	6,649.40	6,530.20	6,358.20	5,882.30	5,653.30
Total Income Growth (%)	1.83	2.71	8.09	4.05	1.12
Total Expenses	5,818.90	5,750.50	5,580.20	5,204.90	5,033.50
Total Expenses Growth (%)	1.19	3.05	7.21	3.41	1.69
EBIT	830.50	779.70	778.00	677.40	619.80
EBIT Growth (%)	6.52	0.22	14.85	9.29	-3.26
Profit after Tax (PAT)	529.30	502.30	477.20	432.80	389.60
PAT Growth (%)	5.38	5.26	10.26	11.09	4.65
EBIT Margin (%)	12.49	11.94	12.24	11.52	10.96
Net Profit Margin (%)	7.96	7.69	7.51	7.36	6.89
Basic EPS (₹)	36.82	34.94	33.19	30.10	27.10

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	2,528.80	2,471.70	2,497.20	2,200.40	2,166.90
Total Income Growth (%)	2.31	-1.02	13.49	1.55	0.19
Total Expenses	1,971.00	1,908.40	1,885.60	1,745.00	1,683.80
Total Expenses Growth (%)	3.28	1.21	8.06	3.63	1.96
EBIT	557.80	563.30	611.60	455.40	483.10
EBIT Growth (%)	-0.98	-7.90	34.30	-5.73	-5.52
Profit after Tax (PAT)	382.40	383.50	419.90	306.90	333.40
PAT Growth (%)	-0.29	-8.67	36.82	-7.95	-2.40
EBIT Margin (%)	22.06	22.79	24.49	20.70	22.29
Net Profit Margin (%)	15.12	15.52	16.81	13.95	15.39
Basic EPS (₹)	26.59	26.67	29.20	21.25	23.18

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	25,420.10	21,994.30	19,165.50	16,702.80	14,740.80
Total Revenue Growth (%)	15.58	14.76	14.74	13.31	39.00
Total Expenses	22,784.90	19,988.20	17,804.90	15,559.10	13,456.80
Total Expenses Growth (%)	13.99	12.26	14.43	15.62	28.84
Profit after Tax (PAT)	1,941.70	1,445.90	898.60	819.10	1,055.60
PAT Growth (%)	34.29	60.91	9.71	-22.40	601.86
Operating Profit Margin (%)	12.22	11.30	9.49	9.17	11.33
Net Profit Margin (%)	7.69	6.63	4.71	4.93	7.19
Basic EPS (₹)	135.04	100.56	62.50	56.97	73.42

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	9,698.00	8,549.80	7,453.70	6,676.30	6,145.30
Total Revenue Growth (%)	13.43	14.71	11.64	8.64	-32.99
Total Expenses	7,740.30	6,861.30	6,125.10	5,448.80	5,286.30
Total Expenses Growth (%)	12.81	12.02	12.41	3.07	-41.17
Profit after Tax (PAT)	1,492.60	1,296.30	1,010.50	1,084.80	665.20
PAT Growth (%)	15.14	28.28	-6.85	63.08	533.52
Operating Profit Margin (%)	23.58	23.68	21.69	22.47	18.08
Net Profit Margin (%)	16.00	15.80	13.89	16.62	10.90
Basic EPS (₹)	103.81	90.15	70.28	75.45	46.25

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 1.78% of its operating revenues towards interest expenses and 11.89% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	22,196.90	20,657.40	16,753.10	14,427.80	13,192.40
Total Assets Growth (%)	7.45	23.30	16.12	9.36	15.55
Total Liabilities	12,222.40	12,004.50	9,432.60	7,896.50	7,314.70
Total Liabilities Growth (%)	1.82	27.27	19.45	7.95	10.59
Total Equity	9,974.50	8,652.90	7,320.50	6,531.30	5,877.70
Total Equity Growth (%)	15.27	18.20	12.08	11.12	22.39
Current Ratio (x)	1.06	1.54	1.13	1.30	1.73
Total Debt to Equity (x)	0.60	0.64	0.46	0.44	0.47
Contingent Liabilities	0.00	1,335.60	789.90	732.40	658.10

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	14,914.50	13,372.30	12,405.20	10,780.40	10,408.20
Total Assets Growth (%)	11.53	7.80	15.07	3.58	6.98
Total Liabilities	4,951.30	4,638.10	4,694.30	3,855.60	4,297.50
Total Liabilities Growth (%)	6.75	-1.20	21.75	-10.28	-5.08
Total Equity	9,963.20	8,734.20	7,710.90	6,924.80	6,110.70
Total Equity Growth (%)	14.07	13.27	11.35	13.32	17.48
Current Ratio (x)	1.74	2.44	2.68	2.53	2.91
Total Debt to Equity (x)	0.18	0.20	0.25	0.25	0.33
Contingent Liabilities	0.00	977.40	649.80	928.80	863.40

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	2,855.70	2,136.40	1,920.20	1,376.70	1,628.00
Net Cash used in Investing Activities	-2,148.20	-3,380.60	-1,537.20	-870.60	-778.20
Net Cash flow from Financing Activities	-477.60	1,316.80	-311.10	-633.00	-792.60
Net Cash Flow	229.90	72.60	72.00	-113.10	157.80
Closing Cash & Cash Equivalent	811.30	578.10	505.40	433.40	583.00
Closing Cash & Cash Equivalent Growth (%)	40.34	14.38	16.61	-25.66	37.11
Total Debt/ CFO (x)	1.98	2.47	1.65	1.97	1.62

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	2,059.00	1,741.90	1,191.40	1,224.50	1,201.00
Net Cash used in Investing Activities	-1,413.00	-1,045.70	-835.30	-588.50	-444.80
Net Cash flow from Financing Activities	-536.70	-739.10	-297.00	-778.60	-637.20
Net Cash Flow	109.30	-42.90	59.10	-142.60	120.30
Closing Cash & Cash Equivalent	342.50	233.20	276.10	217.00	359.60
Closing Cash & Cash Equivalent Growth (%)	46.87	-15.54	27.24	-39.66	50.27
Total Debt/ CFO (x)	0.88	1.02	1.64	1.44	1.69

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 2148.2 cr for investing activities which is an YoY decrease of 36.46%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	20.48	17.60	12.95	13.21	18.77
Return on Capital Employed (%)	19.62	15.32	14.97	13.73	15.38
Return on Assets (%)	8.74	6.99	5.36	5.67	8.00
Interest Coverage Ratio (x)	8.81	7.03	5.56	5.62	5.98
Asset Turnover Ratio (x)	1.18	1.17	1.22	0.54	0.56
Price to Earnings (x)	55.25	66.23	102.04	75.76	61.73
Price to Book (x)	11.27	11.60	13.17	10.00	11.55
EV/EBITDA (x)	28.24	30.91	37.63	30.02	29.51
EBITDA Margin (%)	15.70	14.78	13.10	12.88	15.43

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	14.98	14.84	13.10	15.66	10.88
Return on Capital Employed (%)	16.57	16.28	14.30	15.37	11.96
Return on Assets (%)	10.00	9.69	8.14	10.06	6.39
Interest Coverage Ratio (x)	11.17	9.42	7.92	7.68	6.01
Asset Turnover Ratio (x)	0.66	0.64	0.63	0.62	0.61
Price to Earnings (x)	71.94	73.53	90.91	57.14	98.04
Price to Book (x)	10.72	10.90	11.85	8.95	10.63
EV/EBITDA (x)	40.11	40.31	47.01	34.59	45.29
EBITDA Margin (%)	28.94	29.16	27.18	28.09	24.04

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 20.48% in year ending Mar 31, 2026 outperforming its 5 year avg. of 16.9%. (Source: Consolidated Financials)

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
44%
Positive Movement
since 1st Jan 2005
on basis
56%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 8586.50 Pivot
8476.00
S1 8413.50
R2 8649.00 S2 8303.00
R3 8822.00 S3 8130.00
Average True Range
5 Days 14 Days 28 Days
185.22 176.14 170.05

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Apollo Hospital	63.12	12.29	20.48	19.62	8.74	14.87	12.22	7.76	135.04	1.06	0.60	1.98
Max Healthcare	67.68	9.08	13.42	13.02	8.37	21.75	23.39	17.22	14.83	0.89	0.32	2.13
Fortis Healthcare	71.73	7.35	10.52	12.17	6.52	12.87	18.47	11.47	13.80	0.86	0.29	1.79
Aster DM Health	105.50	8.47	8.48	10.68	4.78	-26.28	16.41	9.99	7.53	1.99	0.15	1.07
Narayana Hruday	49.07	8.71	17.75	11.91	6.45	20.10	16.07	10.20	39.67	2.15	1.07	3.01
Add More

Annual Ratios (%)

Choose from Peers

Global Health
Krishna Instt of Medical Sciences
Dr. Agarwals Health
Rainbow Childrens
Healthcare Global

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Found Peer Comparison useful?

Shareholding Pattern

Total Shareholdings

Category	No. of Shares	Percentage	% Change QoQ
Promoters	4,02,87,130	28.02 %	0.00
Pledge	10,05,054	2.49 %	0.00
FII	6,12,77,722	42.62 %	-0.92
DII	3,25,16,970	22.61 %	1.28
MF	2,39,41,570	16.65 %	-0.10
Others	97,02,835	6.75 %	-0.35

QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 28.02 28.02 28.02 29.34
Pledge 2.49 2.49 8.58 13.11
FII 42.62 43.54 44.20 43.49
DII 22.61 21.33 20.98 21.21
Mutual Funds 16.65 16.75 16.48 15.94
Others 6.75 7.10 6.79 5.96

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Axis Large Cap Direct-G
Equity: Large Cap
1
- 794.69
  Amount Invested (in Cr.)
- 2.60569497%
  % of AUM
- 0.00
  % Change (MoM basis)
HDFC Flexi Cap Direct-G
Equity: Flexi Cap
5
- 553.65
  Amount Invested (in Cr.)
- 0.55%
  % of AUM
- 0.00
  % Change (MoM basis)
Mirae Asset Large Cap Direct-G
Equity: Large Cap
3
- 532.79
  Amount Invested (in Cr.)
- 1.39329677%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Apollo Hospital Futures & Options

Type
Expiry Month
Strike Price

Date	Price	Open Interest
30-06-2026Current	162.8560.55 (59.19%)	33,7502,750 (8.87%)
116.75 Open	172.00 High	111.20 Low
102.30 Close	990 Contracts Traded	10,770.15 Turnover (₹ Lakhs)

Open Interest as of 09 Jun 2026

Expiry MonthPlease select expiry month:

Date	Price	Open Interest
30-06-2026Current	8,564.50164.00 (1.95%)	19,35,0002,23,250 (13.04%)
8,412.00 Open	8,575.00 High	8,398.00 Low
8,400.50 Prev Close	4,867 Contracts Traded	51,873.43 Turnover (₹ Lakhs)

Open Interest as of 09 Jun 2026

Apollo Hospital Top Searches

Corporate Actions

Recent
General Meeting
-
May 22, 2026
General Meeting
-
May 20, 2026
Final
200%
May 20, 2026

Announced on	Meeting on
May 04, 2026	May 20, 2026
Audited Results & Final Dividend
Feb 05, 2026	Feb 10, 2026
Quarterly Results, Int. Dividend & Others
Oct 14, 2025	Nov 06, 2025
Quarterly Results
Jul 17, 2025	Aug 12, 2025
Quarterly Results & Others
May 06, 2025	May 30, 2025
Audited Results, Final Dividend & A.G.M.

Dividends
Announced on Ex-Date Dividend%
Feb 10, 2026 Feb 16, 2026 200%
May 30, 2025 Aug 19, 2025 200%
Feb 10, 2025 Feb 14, 2025 180%
May 30, 2024 Aug 16, 2024 200%
May 20, 2026 - 200%
Bonus
No Data Available
Splits
Announced on Ex-Date
May 28, 2010 Sep 02, 2010
Split: Old FV10.0| New FV:5.0
Rights
Announced on Ex-Date
Sep 30, 1993 Mar 10, 1993
Rights ratio: 1 share for every 1 held at a price of Rs 20.0
AGM/EGM Meetings
Announced on Meeting on
May 22, 2026 Jun 24, 2026
-
May 20, 2026 Aug 25, 2026
-
May 30, 2025 Aug 29, 2025
-
Jul 15, 2024 Aug 19, 2024
-
May 30, 2024 -
-

About Apollo Hospital

Apollo Hospitals Enterprise Ltd., incorporated in the year 1979, is a Large Cap company (having a market cap of Rs 1,22,562.04 Crore) operating in Hospitals & Allied Services sector.

Apollo Hospitals Enterprise Ltd. key Products/Revenue Segments include HealthCare Services and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 6,649.40 Crore, up 1.83 % from last quarter Total Income of Rs 6,530.20 Crore and up 17.62 % from last year same quarter Total Income of Rs 5,653.30 Crore. Company has reported net profit after tax of Rs 541.20 Crore in latest quarter.

The company’s top management includes Dr.Prathap C Reddy, Mrs.Preetha Reddy, Mrs.Suneeta Reddy, Mrs.Sangita Reddy, Dr.Madhu Sasidhar, Mrs.Shobana Kamineni, Mr.M B N Rao, Dr.Murali Doraiswamy, Mrs.Rama Bijapurkar, Dr.Som Mittal, Mrs.V Kavitha Dutt, Mr.Krishnan Akhileswaran, Mr.S M Krishnan. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2026, the company has a total of 14.38 Crore shares outstanding.

Apollo Hospital Share Price Today is Rs. 8524.00. On previous day, the Apollo Hospital Share Price (NSE) closed at Rs. 8358.5, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 28.02% of the stake in Apollo Hospital shares, out of which 2.49% was pledged. On the same date, foreign institutional investors' (FII) holdings of Apollo Hospital stocks was 42.62% as compared to 43.54% in Dec 2025 with decrease of 0.92%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 22.62% as compared to 21.33% in Dec 2025 with increase of 1.29%. Out of the total DII holdings in Apollo Hospital shares 16.65% was held by mutual funds. The rest including public held is 6.74%. Apollo Hospital stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Apollo Hospital Dividend: Ever since 1979, Apollo Hospital dividends has been paid out around 38 times. As on 09 Jun, 2026, 03:58 PM IST, The overall dividend yield for Apollo Hospital stands at 0.24%. The last dividend paid was on null (Rs. 10.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 135.04.

Apollo Hospital Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 6649.4 Cr. of sales and 1.83% of quarterly net profit, there have been multiple ups and downs in the Apollo Hospital stock prices in the past few weeks. For example, Apollo Hospital stock price on 2nd of June 2026 was around Rs. 8089.5. Apollo Hospital share price now stands at an average of Rs. 8524.00. Judging by last week's performance, stock is in up trend.

Apollo Hospital has a median target price of Rs. 9177.32 in 12 months by 25 analysts. They have provided a high estimate of Rs. 9979.0 and low estimate of Rs. 6230.0 for Apollo Hospital share.

Historical Prices and Performance:
Apollo Hospital, incorporated in 1979 is a Large Cap company (with a market cap of Rs. 122562.04) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Apollo Hospital stock was 20.48%, 17.6%, 12.95%, 13.21% and 18.77% respectively.
The Apollo Hospital share gave a 3 year return of 73.02% as compared to Nifty 50 which gave a return of 25.2%.
Apollo Hospital announced 200.0% final dividend on null.

Key Metrics:
PE Ratio of Apollo Hospital is 61.9
Prices/Sales Ratio of Apollo Hospital is 4.23
Price/Book Ratio of Apollo Hospital is 12.05

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Apollo Hospital, major competitors and peers include Max Healthcare, Fortis Healthcare, Aster DM Health and Narayana Hruday. As of Dec 2025, the dividend yield of Apollo Hospital stands at 0.24% while Max Healthcare, Fortis Healthcare, Aster DM Health and Narayana Hruday stand at 0.2%, 0.1%, 0.0% and 0.23% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 61.9 and 12.05 respectively.

Recommendations:
The current total number of analysts covering the stock stands at 26, Three months ago this number stood at 26. Out of total, 11 analyst have a'Strong Buy' reco, 11 analyst have a'Buy' reco, 3 analyst have a'Hold' reco, 1 analyst have a'Sell' reco.

Mean recommendations by 26 analyst stand at'Buy'.

Leadership of Apollo Hospital :
S M Krishnan is Sr. Vice President & Co. Secretary
Krishnan Akhileswaran is Chief Financial Officer
Madhu Sasidhar is President & CEO - Hospitals Division
Dinesh Madhavan is President - Group Oncology & International
Prathap C Reddy is Founder & Chairman
Preetha Reddy is Executive Vice Chairperson
Suneeta Reddy is Managing Director
Sangita Reddy is Joint Managing Director
Shobana Kamineni is Non Exe.Non Ind.Director
V Kavitha Dutt is Independent Director
Murali Doraiswamy is Independent Director
Rama Bijapurkar is Independent Director
Som Mittal is Independent Director
M B N Rao is Lead Independent Director

Show More

Industry

Key Indices Listed On

Nifty 50, Nifty 100, Nifty 200, Nifty 500, BSE 500

Address

No.19, Bishop Gardens,Raja Annamalaipuram,Chennai (Madras), Tamil Nadu - 600028

Contact

investor.relations@apollohospitals.com

https://www.apollohospitals.com

Executive Leadership

PC

Prathap C Reddy

Founder & Chairman

PR

Preetha Reddy

Executive Vice Chairperson

SR

Suneeta Reddy

Managing Director

SR

Sangita Reddy

Joint Managing Director

Show More

Auditors

Deloitte Haskins & Sells LLP

FAQs about Apollo Hospital share

1. What's Apollo Hospital share price today and what are Apollo Hospital share returns ?
Apollo Hospital share price is Rs 8,524.00 as on 09 Jun, 2026, 03:58 PM IST. Apollo Hospital share price is up by 1.99% based on previous share price of Rs. 8358.5.
2. What is the market cap of Apollo Hospital?
Within the Hospitals & Allied Services sector, Apollo Hospital stock has a market cap rank of 1. Apollo Hospital has a market cap of Rs 1,22,562 Cr.
3. What is the PE & PB ratio of Apollo Hospital?
The PE ratio of Apollo Hospital stands at 63.12, while the PB ratio is 12.29.
4. What is Apollo Hospital's 52 week high / low?
52 Week high of Apollo Hospital share is Rs 8,538.50 while 52 week low is Rs 6,696.50
5. What are the returns for Apollo Hospital share?
Return Performance of Apollo Hospital Shares:
- 1 Week: Apollo Hospital share price moved up by 2.82%

Top Gainers

As on 03:43 PM | 09 Jun 2026

Data Patterns (India)

4,558.50

417.20 (10.08%)

3,417.70

252.50 (7.98%)

2,866.40

185.60 (6.93%)

2,255.20

144.20 (6.84%)

5,835.00

362.00 (6.62%)

Top Losers

As on 03:59 PM | 09 Jun 2026

Tata Technologies

745.10

-34.50 (-4.43%)

1,097.80

-45.11 (-3.95%)

107.62

-3.47 (-3.13%)

Krishna Instt of Medical Sciences

781.60

-19.61 (-2.45%)

Balrampur Chini

536.95

-13.45 (-2.45%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.